The guanylate cyclase stimulator BAY 41-2272 does not prevent right ventricular hypertrophy and failure alone or in combination with sildenafil

被引：0
|
作者：
Andersen, A. [1 ]
Nielsen, J. M. [1 ]
Holmboe, S. [1 ]
Vildbrad, M. D. [1 ]
Nielsen-Kudsk, J. E. [1 ]
机构：
[1] Aarhus Univ Hosp, DK-8000 Aarhus, Denmark
来源：
EUROPEAN HEART JOURNAL | 2012年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：113 / 113
页数：1
相关论文
共 50 条
  • [21] The Effects of Cyclic Guanylate Cyclase Stimulation on Right Ventricular Hypertrophy and Failure Alone and in Combination With Phosphodiesterase-5 Inhibition
    Andersen, Asger
    Nielsen, Jan M.
    Holmboe, Sarah
    Vildbrad, Mads D.
    Nielsen-Kudsk, Jens E.
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2013, 62 (02) : 167 - 173
  • [22] Bay 41-2272, an activator of SGC, blunts development of pulmonary hypertension and right ventricular hypertrophy in chronic hypoxic rats.
    Thorsen, LBJ
    Laursen, BE
    Simonsen, U
    HYPERTENSION, 2005, 46 (04) : 909 - 909
  • [23] Effects Of Soluble Guanylate Cyclase Activator BAY 41-2272 In Murine Models Of Pulmonary Hypertension And Acute Lung Injury
    Voelker, M. T.
    Hoelman, A.
    Fichtner, F.
    Sack, U.
    Kamprad, M.
    Busch, T.
    Kaisers, U.
    Laudi, S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181
  • [24] Anti-leukocyte properties of a novel non NO-based soluble guanylate cyclase activator, BAY 41-2272
    Foster, P
    Mathur, A
    McLean, P
    Perretti, M
    Moncada, S
    Ahluwalia, A
    Hobbs, A
    FASEB JOURNAL, 2003, 17 (05): : A1052 - A1052
  • [25] BAY 41-2272: A stimulator of soluble guanylyl cyclase induces nitric oxide-dependent penile erection in vivo
    Bischoff, E
    Schramm, M
    Straub, A
    Feurer, A
    Stasch, JP
    UROLOGY, 2003, 61 (02) : 464 - 467
  • [26] The anti-aggregating effect of BAY 41-2272, a stimulator of soluble guanylyl cyclase, requires the presence of nitric oxide
    Roger, Severine
    Badier-Commander, Cecile
    Paysant, Jerome
    Cordi, Alex
    Verbeuren, Tony J.
    Feletou, Michel
    BRITISH JOURNAL OF PHARMACOLOGY, 2010, 161 (05) : 1044 - 1058
  • [27] Novel soluble guanylyl cyclase stimulator BAY 41-2272 attenuates ischemia-reperfusion-induced lung injury
    Egemnazarov, Bakytbek
    Sydykov, Akylbek
    Schermuly, Ralph T.
    Weissmann, Norbert
    Stasch, Johannes-Peter
    Sarybaev, Akpai S.
    Seeger, Werner
    Grimminger, Friedrich
    Ghofrani, Hossein A.
    AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2009, 296 (03) : L462 - L469
  • [28] Increased sensitivity to the NO-independent soluble guanylyl cyclase stimulator BAY 41-2272 in aorta from eNOS -/- mice
    Teixeira, Cleber E.
    Priviero, Fernanda B.
    Zemse, Sailprasad M.
    Hilgers, Rob H.
    Webb, R. Clinton
    HYPERTENSION, 2006, 48 (04) : E93 - E93
  • [29] Mechanisms underlying relaxation of rabbit aorta by BAY 41-2272, a nitric oxide-independent soluble guanylate cyclase activator
    Priviero, FBM
    Baracat, JS
    Teixeira, CE
    Claudino, MA
    De Nucci, G
    Antunes, E
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2005, 32 (09) : 728 - 734
  • [30] New route to 1-hetarylcyclopropan-1-ols: Synthesis of the pharmacologically active metabolite of bay 41-2272, a stimulator of soluble guanylate
    Belov, VN
    Savchenko, AI
    Sokolov, VV
    Straub, A
    de Meijere, A
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 222 : U683 - U683
12345